Literature DB >> 7233971

Biotransformation of tolmesoxide in animals and man.

D Greenslade, M E Havler, M J Humphrey, B J Jordan, C J Lewis, M J Rance.   

Abstract

1. The excretion and metabolism of tolmesoxide ((4,5-dimethoxy-2-methylphenyl)-methylsulphoxide) has been studied in rat, dog and man. In all species, absorption of oral doses of [14C]tolmesoxide was virtually complete and 78--99% of the 14C was excreted in the urine. 2. In bile-duct cannulated rats, excretion in bile and urine was 49% and 53% dose respectively. Metabolites of tolmesoxide in bile undergo enterohepatic circulation with final elimination by the kidneys. 3. Quantification and identification of metabolites in urine (0-24 h) were obtained by two-dimensional t.l.c. Tolmesoxide was extensively metabolized in all animal species. 4. The major routes of metabolism in rat, dog and man were oxidation to sulphones and O-demethylation followed by sulphate or glucuronide conjugation. Little or none of the urinary 14C was present as sulphide derivatives.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7233971     DOI: 10.3109/00498258109045278

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  1 in total

1.  Pharmacokinetics of intravenous and oral tolmesoxide.

Authors:  J G Lloyd-Jones; R Henson; J D Nichols; D Greenslade; J M Clifford
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.